- Home
- Products
- Services
- Resources
- About Us
- News
- Contact
loading
Intended Use
gDNA NIPT Reference Standard can be used for precision testing, stability testing, and sensitivity testing in non-invasive prenatal testing(NIPT) laboratories. This method uses gDNA human cell lines to screen for common aneuploidy chromosomal abnormalities.
It can monitor the process quality control of sample extraction, library preparation, on-machine sequencing, and data analysis of non-invasive prenatal testing(NIPT) kits.
Product features
Entire workflow quality control
The gDNA NIPT Reference Standard uses gDNA derived from human cell lines as raw material, simulating real clinical samples. It can monitor the quality control of sample extraction, library preparation, and sequencing in non-invasive prenatal testing (NIPT) kits.
Comprehensive coverage of variants for workflow performance evaluation
The gDNA NIPT Reference Standard covers common chromosomal abnormalities as well as pathogenic copy number variations ranging from 2Mb to 30 Mb.
Strict QC quality inspection, stable quality
CB-GENE products are strictly QC inspected in accordance with ISO9001 quality system to ensure stable quality of each batch.
Product data display
In the process of detection, quality control products and reference products are indispensable. For NIPT detection, CB-Gene has launched chromosome aneuploidy reference products and quality control products, including autosomes and sex chromosomes, as well as microdeletion and microduplication quality control products and reference products. In the future, chimera reference products will be launched one after another.
Product Name | Chromosomal abnormalities | Catalog ID | |
Common and Rare Chromosomal Aneuploidy standards | Trisomy 21(47,XX,+21) Reference Standard | Chromosome 21 trisomy standard, female | CBPJ0001 |
Trisomy 18(47,XX,+18) Reference Standard | Chromosome 18 trisomy standard, female | CBPJ0002 | |
Trisomy 21(47,XY,+21) Reference Standard | Chromosome 21 trisomy standard, male | CBPJ0009 | |
Trisomy 13(47,XY,+13) Reference Standard | Chromosome 13 trisomy standard, male | CBPJ0010 | |
Trisomy 9(47,XY,+9) Reference Standard | Chromosome 9 trisomy standard, male | CBPJ0014 | |
Trisomy 21(47,XY,+21) Reference Standard-2 | Chromosome 21 trisomy standard,male | CBPJ0016 | |
Sex Chromosome Aneuploidy Standards | Klinefelter Syndrome (47，XXY) Reference Standard | X chromosome non-global ploidy standard | CBPJ0005 |
Microdeletion and Microduplication Standards | Trisomy 9 (47,XY,+9, Gain 9p24.3p13.1) Reference Standard | 9q11 microdeletion standard, male | CBPJ0003 |
Angelman syndrome (46,XX,del(15)(q11q13)) Reference Standard | Angelman Syndrome Standards, Female | CBPJ0006 | |
Prader-Willi syndrome (46,XY,del(15)(q11.2q13)) Reference Standard | Prader-Willi syndrome standard, male | CBPJ0007 | |
18P-syndrome (46,XX,del(18)(p11.2)) Reference Standard | 18P-syndrome standard, female | CBPJ0008 | |
DiGeorge syndrome (46,XX,del(22)(q11)) Reference Standard | DiGeorge syndrome standard, female | CBPJ0011 | |
18Q-syndrome (46,XX,del(18)(q22)) Reference Standard | 18Q-syndrome standard, female | CBPJ0013 | |
11q23.3 del (46,XX,del(11)(q23.3)) Reference Standard | 11q23.3 del standard, female | CBPJ0015 | |
Angelman syndrome (46,XY,del(15)(q11.2q13.1)) Reference Standard | Angelman syndrome,male | CBPJ0017 | |
| Prader-Willi syndrome (46,XY,del(15)(q11.2q13.1)) Reference Standard | Prader-Willi syndrome,male | CBPJ0018 | |
Negative control | Normal Karyotype (46,XY) Reference Standard | Normal Karyotype,male | CBPJ0004 |
Intended Use
gDNA NIPT Reference Standard can be used for precision testing, stability testing, and sensitivity testing in non-invasive prenatal testing(NIPT) laboratories. This method uses gDNA human cell lines to screen for common aneuploidy chromosomal abnormalities.
It can monitor the process quality control of sample extraction, library preparation, on-machine sequencing, and data analysis of non-invasive prenatal testing(NIPT) kits.
Product features
Entire workflow quality control
The gDNA NIPT Reference Standard uses gDNA derived from human cell lines as raw material, simulating real clinical samples. It can monitor the quality control of sample extraction, library preparation, and sequencing in non-invasive prenatal testing (NIPT) kits.
Comprehensive coverage of variants for workflow performance evaluation
The gDNA NIPT Reference Standard covers common chromosomal abnormalities as well as pathogenic copy number variations ranging from 2Mb to 30 Mb.
Strict QC quality inspection, stable quality
CB-GENE products are strictly QC inspected in accordance with ISO9001 quality system to ensure stable quality of each batch.
Product data display
In the process of detection, quality control products and reference products are indispensable. For NIPT detection, CB-Gene has launched chromosome aneuploidy reference products and quality control products, including autosomes and sex chromosomes, as well as microdeletion and microduplication quality control products and reference products. In the future, chimera reference products will be launched one after another.
Product Name | Chromosomal abnormalities | Catalog ID | |
Common and Rare Chromosomal Aneuploidy standards | Trisomy 21(47,XX,+21) Reference Standard | Chromosome 21 trisomy standard, female | CBPJ0001 |
Trisomy 18(47,XX,+18) Reference Standard | Chromosome 18 trisomy standard, female | CBPJ0002 | |
Trisomy 21(47,XY,+21) Reference Standard | Chromosome 21 trisomy standard, male | CBPJ0009 | |
Trisomy 13(47,XY,+13) Reference Standard | Chromosome 13 trisomy standard, male | CBPJ0010 | |
Trisomy 9(47,XY,+9) Reference Standard | Chromosome 9 trisomy standard, male | CBPJ0014 | |
Trisomy 21(47,XY,+21) Reference Standard-2 | Chromosome 21 trisomy standard,male | CBPJ0016 | |
Sex Chromosome Aneuploidy Standards | Klinefelter Syndrome (47，XXY) Reference Standard | X chromosome non-global ploidy standard | CBPJ0005 |
Microdeletion and Microduplication Standards | Trisomy 9 (47,XY,+9, Gain 9p24.3p13.1) Reference Standard | 9q11 microdeletion standard, male | CBPJ0003 |
Angelman syndrome (46,XX,del(15)(q11q13)) Reference Standard | Angelman Syndrome Standards, Female | CBPJ0006 | |
Prader-Willi syndrome (46,XY,del(15)(q11.2q13)) Reference Standard | Prader-Willi syndrome standard, male | CBPJ0007 | |
18P-syndrome (46,XX,del(18)(p11.2)) Reference Standard | 18P-syndrome standard, female | CBPJ0008 | |
DiGeorge syndrome (46,XX,del(22)(q11)) Reference Standard | DiGeorge syndrome standard, female | CBPJ0011 | |
18Q-syndrome (46,XX,del(18)(q22)) Reference Standard | 18Q-syndrome standard, female | CBPJ0013 | |
11q23.3 del (46,XX,del(11)(q23.3)) Reference Standard | 11q23.3 del standard, female | CBPJ0015 | |
Angelman syndrome (46,XY,del(15)(q11.2q13.1)) Reference Standard | Angelman syndrome,male | CBPJ0017 | |
| Prader-Willi syndrome (46,XY,del(15)(q11.2q13.1)) Reference Standard | Prader-Willi syndrome,male | CBPJ0018 | |
Negative control | Normal Karyotype (46,XY) Reference Standard | Normal Karyotype,male | CBPJ0004 |
Product features
Entire workflow quality control
NIPT plasma reference are formulated in human plasma matrix which mimicing patient samples and monitoring the entire workflow from extraction.
Compatible with multiple NIPT assay platforms
Matched or simulated maternal-fetal reference standards suit a broad range of NIPT assays such as massively parallel sequencing and single nucleotide polymorphism methods.
Comprehensive coverage of variants for workflow performance evaluation
NIPT plasma reference covers common chromosomal abnormalities as well as pathogenic copy number variations ranging from 2Mb to 30 Mb.
Flexible portfolio of fetal fraction levels
Fetal DNA ratio can be customised to match your assay and to determine the limit of detection.
Product features
Entire workflow quality control
NIPT plasma reference are formulated in human plasma matrix which mimicing patient samples and monitoring the entire workflow from extraction.
Compatible with multiple NIPT assay platforms
Matched or simulated maternal-fetal reference standards suit a broad range of NIPT assays such as massively parallel sequencing and single nucleotide polymorphism methods.
Comprehensive coverage of variants for workflow performance evaluation
NIPT plasma reference covers common chromosomal abnormalities as well as pathogenic copy number variations ranging from 2Mb to 30 Mb.
Flexible portfolio of fetal fraction levels
Fetal DNA ratio can be customised to match your assay and to determine the limit of detection.
Product data display
In the process of detection, quality control products and reference products are indispensable. For NIPT detection, CB-Gene has launched chromosome aneuploidy reference products and quality control products, including autosomes and sex chromosomes, as well as microdeletion and microduplication quality control products and reference products. In the future, chimera reference products will be launched one after another.
Product Name | Chromosomal abnormalities | Catalog ID | |
Common and Rare Chromosomal Aneuploidy standards | Trisomy 21(47,XX,+21) Reference Standard | Chromosome 21 trisomy standard, female | CBPJ0001 |
Trisomy 18(47,XX,+18) Reference Standard | Chromosome 18 trisomy standard, female | CBPJ0002 | |
Trisomy 21(47,XY,+21) Reference Standard | Chromosome 21 trisomy standard, male | CBPJ0009 | |
Trisomy 13(47,XY,+13) Reference Standard | Chromosome 13 trisomy standard, male | CBPJ0010 | |
Trisomy 9(47,XY,+9) Reference Standard | Chromosome 9 trisomy standard, male | CBPJ0014 | |
Trisomy 21(47,XY,+21) Reference Standard-2 | Chromosome 21 trisomy standard,male | CBPJ0016 | |
Sex Chromosome Aneuploidy Standards | Klinefelter Syndrome (47，XXY) Reference Standard | X chromosome non-global ploidy standard | CBPJ0005 |
Microdeletion and Microduplication Standards | Trisomy 9 (47,XY,+9, Gain 9p24.3p13.1) Reference Standard | 9q11 microdeletion standard, male | CBPJ0003 |
Angelman syndrome (46,XX,del(15)(q11q13)) Reference Standard | Angelman Syndrome Standards, Female | CBPJ0006 | |
Prader-Willi syndrome (46,XY,del(15)(q11.2q13)) Reference Standard | Prader-Willi syndrome standard, male | CBPJ0007 | |
18P-syndrome (46,XX,del(18)(p11.2)) Reference Standard | 18P-syndrome standard, female | CBPJ0008 | |
DiGeorge syndrome (46,XX,del(22)(q11)) Reference Standard | DiGeorge syndrome standard, female | CBPJ0011 | |
18Q-syndrome (46,XX,del(18)(q22)) Reference Standard | 18Q-syndrome standard, female | CBPJ0013 | |
11q23.3 del (46,XX,del(11)(q23.3)) Reference Standard | 11q23.3 del standard, female | CBPJ0015 | |
Angelman syndrome (46,XY,del(15)(q11.2q13.1)) Reference Standard | Angelman syndrome,male | CBPJ0017 | |
| Prader-Willi syndrome (46,XY,del(15)(q11.2q13.1)) Reference Standard | Prader-Willi syndrome,male | CBPJ0018 | |
Negative control | Normal Karyotype (46,XY) Reference Standard | Normal Karyotype,male | CBPJ0004 |
Product data display
In the process of detection, quality control products and reference products are indispensable. For NIPT detection, CB-Gene has launched chromosome aneuploidy reference products and quality control products, including autosomes and sex chromosomes, as well as microdeletion and microduplication quality control products and reference products. In the future, chimera reference products will be launched one after another.
Product Name | Chromosomal abnormalities | Catalog ID | |
Common and Rare Chromosomal Aneuploidy standards | Trisomy 21(47,XX,+21) Reference Standard | Chromosome 21 trisomy standard, female | CBPJ0001 |
Trisomy 18(47,XX,+18) Reference Standard | Chromosome 18 trisomy standard, female | CBPJ0002 | |
Trisomy 21(47,XY,+21) Reference Standard | Chromosome 21 trisomy standard, male | CBPJ0009 | |
Trisomy 13(47,XY,+13) Reference Standard | Chromosome 13 trisomy standard, male | CBPJ0010 | |
Trisomy 9(47,XY,+9) Reference Standard | Chromosome 9 trisomy standard, male | CBPJ0014 | |
Trisomy 21(47,XY,+21) Reference Standard-2 | Chromosome 21 trisomy standard,male | CBPJ0016 | |
Sex Chromosome Aneuploidy Standards | Klinefelter Syndrome (47，XXY) Reference Standard | X chromosome non-global ploidy standard | CBPJ0005 |
Microdeletion and Microduplication Standards | Trisomy 9 (47,XY,+9, Gain 9p24.3p13.1) Reference Standard | 9q11 microdeletion standard, male | CBPJ0003 |
Angelman syndrome (46,XX,del(15)(q11q13)) Reference Standard | Angelman Syndrome Standards, Female | CBPJ0006 | |
Prader-Willi syndrome (46,XY,del(15)(q11.2q13)) Reference Standard | Prader-Willi syndrome standard, male | CBPJ0007 | |
18P-syndrome (46,XX,del(18)(p11.2)) Reference Standard | 18P-syndrome standard, female | CBPJ0008 | |
DiGeorge syndrome (46,XX,del(22)(q11)) Reference Standard | DiGeorge syndrome standard, female | CBPJ0011 | |
18Q-syndrome (46,XX,del(18)(q22)) Reference Standard | 18Q-syndrome standard, female | CBPJ0013 | |
11q23.3 del (46,XX,del(11)(q23.3)) Reference Standard | 11q23.3 del standard, female | CBPJ0015 | |
Angelman syndrome (46,XY,del(15)(q11.2q13.1)) Reference Standard | Angelman syndrome,male | CBPJ0017 | |
| Prader-Willi syndrome (46,XY,del(15)(q11.2q13.1)) Reference Standard | Prader-Willi syndrome,male | CBPJ0018 | |
Negative control | Normal Karyotype (46,XY) Reference Standard | Normal Karyotype,male | CBPJ0004 |
